ENANTA PHARMACEUTICALS INC Shares Outstanding

Quick Answer

ENANTA PHARMACEUTICALS INC reported Shares Outstanding of 21.39 million shares for fiscal year 2025.

ENANTA PHARMACEUTICALS INC Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 21.39M +0.9%
2024 21.19M +0.6%
2023 21.06M +1.3%
2022 20.79M +2.7%
2021 20.24M +0.8%
2020 20.08M +1.9%
2019 19.70M +1.6%
2018 19.39M +1.4%
2017 19.12M +0.4%
2016 19.04M +1.7%
2015 18.72M +0.7%
2014 18.59M +3.7%
2013 17.93M +1480.6%
2012 1.13M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
December 31, 2025 29.02M +36.0% +35.7%
June 30, 2025 21.38M +0.9% +0.0%
March 31, 2025 21.38M +0.9% +0.2%
December 31, 2024 21.33M +0.8% -0.3%
September 30, 2024 21.39M +1.6% +1.0%
June 30, 2024 21.18M +0.6% +0.0%
March 31, 2024 21.18M +0.6% +0.1%
December 31, 2023 21.16M +1.3% +0.5%
  • ENANTA PHARMACEUTICALS INC showed an increase of +0.9% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2012–2025 period, ENANTA PHARMACEUTICALS INC’s shares outstanding has grown by 1785.4% (from 1.13 million shares to 21.39 million shares).
  • The most recent figure is from ENANTA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 19, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment